{{Drugbox
| IUPAC_name               = (17β)-3-(cyclopentyloxy)-17-ethynylestra-3,5-dien-17-ol
| image                    = Quingestanol structure.svg
| CAS_number               = 10592-65-1
| CAS_supplemental         = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1A635076CE
| ATC_prefix               = G03
| ATC_suffix               = AC04
| ATC_supplemental         = <br />{{ATC|G03|AA02}} (with an [[estrogen]])
| PubChem                  = 9842127
| ChemSpiderID             = 8017842
| C = 25 | H = 34 | O = 2
| molecular_weight         = 366.536 g/mol
| smiles                   = O(\C4=C\C3=C\C[C@@H]2[C@H](CC[C@]1(C)[C@@](C#C)(O)CC[C@H]12)[C@H]3CC4)C5CCCC5
| StdInChI                 = 1S/C25H34O2/c1-3-25(26)15-13-23-22-10-8-17-16-19(27-18-6-4-5-7-18)9-11-20(17)21(22)12-14-24(23,25)2/h1,8,16,18,20-23,26H,4-7,9-15H2,2H3/t20-,21+,22+,23-,24-,25-/m0/s1
| StdInChIKey              = PCJFRMOEZQQSAX-AIOSZGMZSA-N
| bioavailability          = 
| protein_bound            = 
| metabolism               = 
| elimination_half-life    = 
| excretion                = 
| pregnancy_category       = 
| legal_status             = 
| routes_of_administration = 
}}
{{About|a non-clinically used progestin compound|the pharmaceutical drug|quingestanol acetate}}
'''Quingestanol''' ([[International Nonproprietary Name|INN]], [[British Approved Name|BAN]]), also known as '''norethisterone 3-cyclopentyl enol ether''', is a [[steroid]]al [[progestin]] of the [[19-nortestosterone]] group which was never marketed.<ref name="Macdonald1997">{{cite book | author = F.. Macdonald | title = Dictionary of Pharmacological Agents | url = https://books.google.com/books?id=A0THacd46ZsC&pg=PA1721 | accessdate = 12 May 2012 | year = 1997 | publisher = CRC Press | isbn = 978-0-412-46630-4 | page = 1721}}</ref> It is a [[prodrug]] of [[norethisterone]].<ref name="pmid3543501">{{cite journal | vauthors = Raynaud JP, Ojasoo T | title = The design and use of sex-steroid antagonists | journal = J. Steroid Biochem. | volume = 25 | issue = 5B | pages = 811–33 | year = 1986 | pmid = 3543501 | doi = | url = | quote = Similar androgenic potential is inherent to norethisterone and its prodrugs (norethisterone acetate, ethynodiol diacetate, lynestrenol, norethynodrel, quingestanol).}}</ref><ref name="pmid4853997">{{cite journal | vauthors = Di Carlo FJ, Loo JC, Aceto T, Zuleski FR, Barr WH | title = Quingestanol acetate metabolism in women | journal = Pharmacology | volume = 11 | issue = 5 | pages = 287–303 | year = 1974 | pmid = 4853997 | doi = 10.1159/000136501| url = }}</ref> An [[acylation|acylated]] derivative, [[quingestanol acetate]], is used as a [[pharmaceutical]] [[drug]].<ref name="Macdonald1997" />

==See also==
* [[Lynestrenol]]
* [[Quinestrol]]
* [[Quinestradol]]

==References==
{{Reflist|2}}


{{Progesterone receptor modulators}}
{{Androgen receptor modulators}}

[[Category:Alkynes]]
[[Category:Androgens and anabolic steroids]]
[[Category:Estranes]]
[[Category:Prodrugs]]
[[Category:Progestogens]]
[[Category:Cyclopentanes]]


{{genito-urinary-drug-stub}}
{{steroid-stub}}